Abstract：Objective To systemically review the efficacy of hypophysin combined with Octreotide in the treatment of liver cirrhosis with upper gastrointestinal hemorrhage. Methods The literatures about the efficacy of hypophysin combined with Octreotide in the treatment of upper gastrointestinal hemorrhage were searched systemically in the database of PubMed, The Cochrane Library, Web of Science and WanFang, CNKI, CBM and VIP, the search words included "hypophysin, Octreotide, upper gastrointestinal hemorrhage", the retrieval time limit was from the establishment of database to July 2016, 2 reviewers independently screened literatures according to the inclusion and exclusion criteria, extracted data, and assessed the risk of bias of included studies. Then Meta-analysis was performed using RevMan5.2 software. Results A total of 7 RCTs involving 658 patients were included, including 337 cases in the experimental group and 321 cases in the control group. The results of Meta-analysis showed that the total effective rate of experimental group was higher than that of the control group, the hemostatic time was shorter than that of control group, the differences were all statistically significant (MD = 7.33, 95%CI: 3.83-14.03, P ＜ 0.01; MD = -8.57, 95%CI: -13.62 - -3.52, P ＜ 0.01). There was no significant difference in the incidence of adverse reactions between the two groups (P ＞ 0.05). Conclusion Compared to the single use of Octreotide, hypophysin combined with Octreotide can effectively improve the total effective rate and shorten the hemostatic time.
蔡艳萍1 薛顺和2▲. 垂体后叶素联合奥曲肽治疗肝硬化上消化道出血临床效果的Meta分析[J]. 中国医药导报, 2017, 14(17): 119-122.
CAI Yanping1 XUE Shunhe2▲. Efficacy of hypophysin combined with Octreotide in the treatment of liver cirrhosis with upper gastrointestinal hemorrhage: a Meta-analysis. 中国医药导报, 2017, 14(17): 119-122.
[1] 单成祥，杨宁，杭建飞，等.肝硬化食管静脉曲张破裂出血危险因素的Meta分析[J].第二军医大学学报，2007，28（8）：888-893.
[2] 李伟强，赵智，杨舟.奥曲肽与垂体后叶素联用硝酸甘油治疗食管静脉曲张破裂出血效果比较[J].武警医学，2008， 19（12）：1122-1123.
[3] 张鸿飞，朱世殊.肝硬化合并上消化道出血临床治疗[J].中国实用内科杂志，2010，30（11）：974-976.
[4] Jadad AR，Moore RA，Carroll D，et al. Assessing the quality of reports of randomized clinical trials：is blinding necessary? [J]. Control Clin Trials，1996，17（1）：1-12.
[5] 申淑莲.小剂量垂体后叶素，奥曲肽联用治疗上消化道大出血的临床分析[J].中国医药指南，2012，10（27）：128-129.
[6] 戚敬虎，郝云华，乔白洁，等.奥曲肽联合小剂量垂体后叶素治疗肝硬化上消化道出血的疗效观察[J].青岛医药卫生，2011，42（5）：332-333.
[7] 刘伟，李珊珊，周磊，等.奥曲肽与垂体后叶素联合治疗肝硬化失代偿期第一次上消化道出血的临床观察[J].中华全科医学，2014，12（10）：1678-1679.
[8] 陈观荣，冼飞，宁观林.垂体后叶素联合奥曲肽治疗肝硬化上消化道出血疗效观察[J].现代医药卫生，2012，28（24）：3740-3742.
[9] 吴建辉，刘小梅，杨京帆，等.垂体后叶素联合奥曲肽治疗肝硬化上消化道出血60例疗效观察[J].齐齐哈尔医学院学报，2013，34（10）：1470-1471.
[10] 潘宏强，唐国文，蔡政友.垂体后叶素联合奥曲肽治疗肝硬化并上消化道出血的疗效[J].实用临床医学，2014， 15（1）：10-12.
[11] 赖永威.垂体后叶素与奥曲肽治疗肝硬化上消化道出血的临床研究[J].临床医学工程，2012，19（7）：1104-1105.
[12] 叶艳.奥曲肽联合垂体后叶素治疗肝硬化并上消化道出血31例临床疗效观察[J].中国医药导报，2010，7（13）：207-207.
[13] 张茶丽，于红刚.奥曲肽联合质子泵抑制剂治疗非静脉曲张上消化道出血的Meta分析[J].胃肠病学和肝病学杂志，2012，21（6）：528-532.
[14] 陈敏锋，邓启明，林颖华.奥曲肽联合奥美拉唑治疗肝硬化上消化道出血疗效的Meta分析[J].中国当代医药，2013，20（14）：167-169.
[15] 施春雨.奥曲肽与硬化疗法治疗肝硬化食管静脉曲张出血的meta分析[D].吉林：吉林大学，2014.
[16] Cho SB，Lee WS，Park CH，et al. Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study [J]. Korean J Hepatol，2006，12（3）：385-393.
[17] Hwang SJ，Lin HC，Chang CF，et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding [J]. J Hepatol，1992，16（16）：320-325.
[18] Zhou Y，Liang Q，Jing WU，et al. Comparison of the efficacy of octreotide，vasopressin，and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy：A controlled study [J]. J Gastroenterol Hepatol，2002，17（9）：973-979.
2017, Vol. 14 
京公网安备 11010502046598号